Singapore markets closed

Straits Times Index
3,292.93
-3.96(-0.12%)
Nikkei
38,236.07
-37.98(-0.10%)
Hang Seng
18,475.92
+268.79(+1.48%)
FTSE 100
8,213.49
+41.34(+0.51%)
Bitcoin USD
62,718.21
+3,121.67(+5.24%)
CMC Crypto 200
1,359.39
+82.41(+6.45%)

ABT Jan 2025 150.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.1300

-0.0400

(-23.53%)

As of 02:22PM EDT. Market open.

Loading interactive chart…

Zacks
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.